Nick Weber

Nicholas D. Weber, PhD is the Principal Scientist, New Programs and Innovation Lead at Vivet Therapeutics (Pamplona, Spain). Previously, he has held positions at Arbutus Biopharma (Vancouver, Canada) and Fred Hutchinson Cancer Research Center (Seattle, USA) working on gene therapy approaches for HBV infection. His current research focuses on gene editing, viral vectors, translational research, immune response to AAV-mediated gene therapy, durability of therapeutic effect, rare metabolic disorders and liver fibrosis.